PF-Atlas › Clinical Trials › NCT07407543
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males
SRN001 · Phase 1
Registry ID
NCT07407543
Phase
Phase 1
Status
Recruiting
Drug / intervention
SRN001
Sponsor
siRNAgen Therapeutics Inc.
Start
2026-01-05
Enrollment
30
Locations
1
About this trial
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of SRN001 in healthy adult volunteers.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT07407543 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.